Drapalin 10/11 Batha Balanced

Drapalin 10/11 Batha Balanced is a balanced hybrid strain with a harmounious indica-sativa ratio. It is a cross from our internal genetic program between Bafokeng Choice and an early phenotype of Grape Cluster. The target with this strain was to emulate a balanced version of the iconic Grandaddy Purple genetic.

This novel cannabis strain is characterized by a firm flower with a distinct aroma. The terpene profile features a high content of β-caryophyllene, β-myrcene, α-humulene and d-limonene.

Cultivar
Batha Balanced
(Hybrid, Indica / Sativa)
Genetics
Bafokeng Choice x
Grape Cluster 176
THC- / CBD-Content (w/w)
THC 8,5% – 11,5%
CBD 9,5% – 12,5%
Shelf life
12 months
Treatment
not irradiated
Producer
MG Health Limited, Lesotho

Terpen Profile

Main terpenes
β-Caryophyllene 41%
β-Myrcene 31%
α-Humulene 16%
d-Limonene 12%
Properties
antioxidant
antimicrobial
anti-inflammatory
soothing
analgesic
anti-inflammatory
analgesic
antimicrobial
anti-inflammatory
anxiety-relieving
antidepressant
immunostimulant
Aroma
spicy
woody
earthy
fruity
hop-like
woody
citrusy
fresh
Boiling point
130 °C
166 – 168 °C
106 °C
176 °C

Product videos

Drapalin team visit MG Health 2:07
Production of Medical Cannabis at MG Health 9:45

Areas of Applications

Since the prescription of medical cannabis flowers to patients is a formulation prescription, the decision on the therapeutic area of application rests with the prescribing physician. Based on the symptoms, medical cannabis is currently most frequently used in Germany for the following diseases:
Pain
Anorexia / Cachexia
Depression
Lack of appetite
Insomnia
Spasticity
Inflammatory bowel diseases
Epilepsy
ADHD
Multiple Sclerosis
Tic disorders / Tourette Syndrome
Nausea / Vomiting

Drapalin 10/11 Batha Balanced Product Information

THC ~ 10% CBD ≤ 11%
Effect profile
THC / CBD balanced
  • Reduction of side effects
  • Enhancement of therapeutic benefits
Reccomendation
Clinical evidence based on meta-analysis
  • Spasticity
  • Chronic pain
  • Sleep disorders
Medication Intake Medicinal cannabis flowers can be taken both through inhalation (e.g. by means of a vaporizer) and orally (e.g. as a tea preparation). The appropriate route of administration should be determined individually by the prescribing physician together with the patient and must be written down on the prescription.
MG Health is about quality and safety MG Health is a well-established medical cannabis manufacturer and our partner in Lesotho. In this landlocked South African country, the medicinal plant is cultivated at an altitude of 2000m in a mountainous environment far away from any industry. These optimal natural conditions, the qualified personnel, and the state-of-the-art facilities guarantee pharmaceutical production at the highest level.
„When we started this company, we didn’t just want to make a profit, we wanted to change lives, and what better way to do that than through education and jobs?“ Andre Bothma, CEO of MG Health
These Products are Distributed in Germany by Drapalin Drapalin Pharmaceuticals GmbH from Munich has been acting as one of the first German importers and wholesalers of medical cannabis since 2018. Their reliable supply of quality products and the active exchange of knowledge with physicians, pharmacists and patient associations establishes their platform for success. You can find all information on current training courses and offers at: www.drapalin.de/fklogin.
„We are proud to be the first pharmaceutical wholesaler to supply medical cannabis flowers from Africa to pharmacies throughout Germany since August 2021. In doing so, we have made history together with our Lesotho partner MG Health.“ Lana Korneva, CEO of DRAPALIN